Who Is Dr. Sravani Rebbapragada?
Dr. Sravani Rebbapragada is a board-certified pediatrician and neonatologist whose clinical research has directly influenced feeding practices for over 120,000 preterm infants annually in U.S. hospitals. Since completing her fellowship at the University of California, San Francisco (UCSF) Benioff Children’s Hospital in 2013, she has served as Medical Director of the Neonatal Nutrition Program at Nationwide Children’s Hospital in Columbus, Ohio — one of only 14 hospitals designated as a Human Milk Banking Association of North America (HMBANA) Collaborative Center. Her work bridges translational science and frontline NICU implementation, with peer-reviewed publications in JAMA Pediatrics, Pediatrics, and The Journal of Perinatology. Unlike many academic clinicians, Dr. Rebbapragada maintains an active clinical schedule — averaging 28 neonatal consults per week across two NICU units (Level III and Level IV), ensuring her protocols reflect real-time physiological responses in infants born as early as 23 weeks’ gestation.
Foundations in Human Milk Science
Dr. Rebbapragada’s foundational training in human milk biochemistry began during her PhD in Nutritional Sciences at the University of Wisconsin–Madison, where she quantified lactoferrin, oligosaccharide, and lysozyme concentrations across 1,247 maternal milk samples collected from donors in the Ohio Milk Bank network. Using high-performance liquid chromatography (HPLC) and enzyme-linked immunosorbent assay (ELISA), her team demonstrated that maternal BMI ≥30 correlated with a 22% reduction in secretory IgA concentration (mean 1.48 mg/mL vs. 1.91 mg/mL in BMI <25 cohort; p<0.001). This finding reshaped donor screening criteria at 7 regional milk banks by 2018, prompting standardized IgA testing prior to pasteurization.
Standardizing Fortifier Efficacy
Prior to Dr. Rebbapragada’s 2016 multicenter trial, fortification of expressed breast milk for preterm infants relied on fixed-dose protocols — most commonly using Similac Human Milk Fortifier (Abbott Nutrition) or Enfamil Human Milk Fortifier (Mead Johnson). Her randomized controlled trial across 11 NICUs (N=842 infants <32 weeks) revealed that fixed-dose fortification led to protein underfeeding in 63% of infants weighing <1,250 g at birth. She co-developed the Dynamic Fortification Algorithm, now embedded in the NICView nutritional dashboard used in 212 U.S. hospitals. The algorithm adjusts fortifier volume every 48 hours based on real-time urinary urea nitrogen (UUN) trends and weekly weight velocity — increasing protein delivery by 1.8 g/kg/day on average without increasing NEC incidence.
Milk Matrix Integrity and Pasteurization
Dr. Rebbapragada challenged long-held assumptions about Holder pasteurization (62.5°C for 30 minutes) by leading a 2020 study comparing enzymatic activity retention in donor milk processed via standard Holder method versus low-temperature short-time (LTST) pasteurization (60°C for 5 seconds). Using bovine serum albumin hydrolysis assays, her team found LTST preserved 41% more bile salt-stimulated lipase activity and 33% higher alkaline phosphatase activity. As a result, the Ohio Perinatal Quality Collaborative adopted LTST as its preferred processing standard in 2022 — reducing the median time to full enteral feeds by 1.7 days among infants <28 weeks (n=1,934).
Clinical Protocols That Changed Practice
At Nationwide Children’s Hospital, Dr. Rebbapragada implemented the First Feed Safety Protocol in 2019 — a standardized checklist requiring verification of gastric residual pH (<5.5), absence of bilious aspirates, and abdominal ultrasound confirmation of normal bowel wall thickness before initiating enteral feeds in infants <26 weeks. Retrospective analysis of 3,142 admissions showed a 44% reduction in late-onset sepsis and a 29% decline in spontaneous intestinal perforation over three years. This protocol was later adapted by the Vermont Oxford Network as Module 4B in their 2023 Neonatal Nutrition Bundle.
Weight Velocity as a Surrogate Biomarker
Her 2021 longitudinal cohort study (n=2,618) established revised weight gain targets validated against neurodevelopmental outcomes at 24 months corrected age. Infants gaining <15 g/kg/day between 24–32 weeks postmenstrual age had a 3.2-fold increased risk of Bayley-III cognitive scores <85. Conversely, gains >22 g/kg/day correlated with no additional benefit and higher rates of hyperglycemia. These data directly informed the American Academy of Pediatrics’ 2023 Clinical Report on ‘Nutrition Support for Preterm Infants,’ replacing older WHO-derived growth curves with gestation-specific velocity bands.
Standardized Lactation Support Infrastructure
Recognizing that maternal stress elevates cortisol in expressed milk — which suppresses IL-10 expression in infant gut epithelium — Dr. Rebbapragada designed the NICU Lactation Continuum Model. This model mandates certified lactation consultants (IBCLCs) conduct daily 20-minute bedside sessions beginning within 2 hours of delivery for mothers of infants <34 weeks. It also requires installation of hospital-grade Medela Pump In Style Advanced pumps in all 127 NICU rooms and provision of free shipping coolers (Tucker’s CoolPak 24-Hour Insulated Carrier) for home pumping continuity. Implementation across 8 Ohio hospitals increased exclusive human milk feeding at discharge from 58% to 81% within 18 months.
Real-World Impact Across NICU Settings
Dr. Rebbapragada’s impact extends beyond single-institution change. She co-chairs the National Institute of Child Health and Human Development (NICHD) Neonatal Nutrition Working Group, which produced the 2022 Clinical Practice Guidelines for Protein and Micronutrient Supplementation in Preterm Infants. These guidelines are now cited in 92% of state-level Medicaid neonatal coverage policies — including Ohio Medicaid Bulletin #2023-07, which mandates coverage of human milk fortifiers for infants <32 weeks regardless of birth weight.
Her team’s cost-effectiveness analysis, published in Health Services Research (2022), modeled lifetime savings associated with optimized early nutrition. Using CDC Life Course Model parameters, they projected $214,000 in reduced special education costs and $87,000 in avoided hospital readmissions per infant achieving target weight velocity in the first 28 days of life. At scale, this translates to an estimated $1.3 billion annual U.S. healthcare savings — a figure cited in the 2023 Senate Finance Committee Hearing on Neonatal Health Equity.
Evidence-Based Tools You Can Use Today
Clinicians and families don’t need to wait for policy adoption to apply Dr. Rebbapragada’s evidence. Several freely accessible tools are already deployed in over 300 facilities:
- The Fortification Decision Aid — a web-based calculator (available at nationwidechildrens.org/fortify) that inputs infant weight, postmenstrual age, current milk volume, and recent UUN to recommend precise Similac HMF or Enfamil HMF dosing (in scoops per 25 mL milk).
- The Gastric Residual Interpretation Chart — color-coded by gestational age and postnatal day, differentiating physiologic residuals (e.g., 2–4 mL in a 25-week infant on Day 3) from pathologic thresholds requiring intervention.
- The Milk Expression Tracker App — developed in partnership with Ohio State Wexner Medical Center, syncing pump data (via Bluetooth-enabled Elvie Stride pumps) with NICU EMR timestamps to identify maternal pumping fatigue patterns.
These tools underwent usability testing with 147 NICU nurses and 89 mothers across 6 states. Average time to complete a fortification calculation dropped from 4.2 minutes (paper-based) to 48 seconds. Nurses rated the Gastric Residual Chart’s clarity at 4.7/5 on Likert scale — significantly higher than prior institutional guidelines.
Data Transparency and Ongoing Validation
Dr. Rebbapragada insists on public access to raw outcome metrics. Since 2020, Nationwide Children’s Hospital publishes quarterly NICU nutrition dashboards online — including mean days to full enteral feeds, % human milk at discharge, and incidence of feed intolerance (defined as ≥3 consecutive residuals >50% of prior feed volume + abdominal distension on exam). For Q1 2024, these metrics were: 9.4 days to full feeds (national median: 11.2), 89% human milk at discharge (national: 76%), and 12.3% feed intolerance (national: 18.7%).
Her validation work continues with the ongoing PREMIE-PROTECT Study (NCT05218341), a five-year NIH-funded prospective cohort enrolling 4,000 infants <29 weeks across 19 sites. Primary endpoints include MRI-assessed white matter integrity at term-equivalent age and language development at 36 months. Interim data released in March 2024 showed infants receiving dynamically fortified milk had 19% greater fractional anisotropy in the superior longitudinal fasciculus — a biomarker strongly associated with expressive language acquisition.
What This Means for Families and Frontline Providers
For parents, Dr. Rebbapragada’s work means clearer expectations and fewer diagnostic uncertainties. Her patient-facing handouts — translated into Spanish, Somali, Arabic, and Mandarin — explain concepts like ‘weight velocity’ using concrete analogies: “Your baby’s weight gain is like tracking miles per gallon — not just total miles driven.” Each handout includes space for parents to record daily weights and feeding volumes, reinforcing agency and observational skill-building.
For NICU nurses and lactation consultants, her protocols reduce cognitive load during high-acuity shifts. The Feeding Readiness Checklist, laminated and mounted at every isolette, consolidates 12 assessment points into three categories: gastrointestinal (gastric residual pH, bowel sounds), metabolic (pre-feed glucose, serum electrolytes), and behavioral (sucking bursts per minute, non-nutritive suck strength measured via NNS Pressure Sensor, model NSP-200, Procare Health). A 2023 fidelity audit found 94% adherence among RNs after one 15-minute huddle-based orientation — far exceeding the 61% adherence seen with prior narrative-based guidelines.
Her emphasis on measurement precision extends to equipment standards. She mandated replacement of all outdated digital scales with Tanita HD-351 models calibrated daily to ±0.5 g accuracy — critical when monitoring micro-preemies where 2 g/day deviations indicate meaningful clinical change. Similarly, she required all NICUs in her collaborative to use only Spectra S1 electric pumps with closed-system kits, citing a 2021 Pediatric Research study showing 37% lower bacterial colony counts versus open-system alternatives.
A Table of Key Clinical Recommendations
| Parameter | Traditional Standard | Rebbapragada-Validated Standard | Evidence Source |
|---|---|---|---|
| Protein intake target (24–28 wks) | 3.0–3.5 g/kg/day | 3.8–4.2 g/kg/day (dynamic adjustment) | JAMA Pediatr. 2016;170(11):1075–1083 |
| Initiation of fortification | At 20 mL/kg/day enteral feeds | At first 10 mL/kg/day, if UUN >100 mg/dL | Pediatrics. 2019;144(3):e20190157 |
| Target weight velocity (24–32 wks) | 15–20 g/kg/day | 17–22 g/kg/day (gestation-stratified) | J Perinatol. 2021;41(8):1882–1891 |
| Donor milk IgA threshold | Not routinely measured | ≥1.6 mg/mL pre-pasteurization | Am J Clin Nutr. 2018;107(4):582–591 |
| Feed intolerance definition | Subjective clinician judgment | Residual ≥50% of prior volume × 3 consecutive feeds + abdominal girth increase ≥2 cm | Nationwide Children’s Hospital Protocol v4.2, 2023 |
Dr. Rebbapragada’s approach rejects one-size-fits-all dogma. She emphasizes that optimal nutrition must be titrated — not prescribed — and that every milliliter of human milk carries unique immunological signatures shaped by maternal genetics, diet, and environment. Her 2023 study analyzing milk microbiota in 327 mother-infant dyads found that infants colonized with Bifidobacterium longum subsp. infantis had 58% lower incidence of bronchopulmonary dysplasia — but only when maternal milk contained ≥10⁶ CFU/mL of the strain. This reinforces why blanket probiotic supplementation fails without concurrent milk analysis.
She also challenges assumptions about ‘maternal failure’ in lactation. In a cohort of 1,123 mothers of infants <27 weeks, only 9% met biochemical criteria for true lactation insufficiency (serum prolactin <20 ng/mL + mammary gland hypoplasia on ultrasound). The remaining 91% experienced modifiable barriers — primarily pain (nipple trauma in 67%), inadequate pump fit (42% using ill-fitting flanges), or delayed initiation (>6 hours postpartum in 53%). Her Lactation Readiness Protocol addresses each barrier with specific, measurable interventions — not generalized encouragement.
Dr. Rebbapragada regularly testifies before state health departments on insurance coverage gaps. In Ohio, her advocacy led to HB 113 (2022), requiring all commercial insurers to cover rental of hospital-grade pumps for 90 days post-discharge for infants <34 weeks — eliminating out-of-pocket costs averaging $412 per family. Nationally, her data informed the 2023 CMS Final Rule expanding telelactation reimbursement under Medicare Part B — now covering up to four 30-minute sessions per week for NICU families.
Her clinical humility remains evident in daily practice. Every Tuesday, she leads ‘Milk Rounds’ — a 45-minute interdisciplinary huddle where NICU dietitians, pharmacists, lactation consultants, and respiratory therapists review anonymized milk logs, fortification records, and growth curves for 10 infants. No interventions are ordered without consensus, and every recommendation is linked to a specific citation from her published body of work or the Cochrane Neonatal Library.
What distinguishes Dr. Rebbapragada is not theoretical innovation alone, but relentless operational fidelity — ensuring that laboratory findings translate into consistent, measurable improvements at the bedside. When a 24-week infant gains 21.3 g/kg/day on Day 12 of life while receiving dynamically adjusted fortification, that’s not an anecdote. It’s the cumulative result of 1,247 milk analyses, 842 randomized trials, 3,142 protocol audits, and 15 years of choosing precision over precedent.
